Analysis of the p53 tumor suppressor gene by pyrosequencing.

Tumor suppressor genes are implicated in cell cycle progression. Inactivation of these genes predominantly occurs through mutations and/or allelic loss that involves both alleles. With inactivation by multiple mutations in a single gene, cloning of the amplified gene is necessary to determine whether the mutations reside on one or both alleles. Using pyrosequencing, a recently developed approach based on sequencing-by-synthesis, we studied genetic variability in the p53 tumor suppressor gene and could quantify the ratio between the mutated and wild-type amplified fragments. Furthermore, this sequencing technique also allows allelic determination of adjacent mutations with no cloning of amplified fragments.

[1]  M. Uhlén,et al.  Truncated fragments in polymerase chain reaction‐based DNA sequencing , 1999, Electrophoresis.

[2]  M Ronaghi,et al.  Analyses of secondary structures in DNA by pyrosequencing. , 1999, Analytical biochemistry.

[3]  O. Hino,et al.  Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma , 1998, International journal of cancer.

[4]  M. Ronaghi,et al.  A Sequencing Method Based on Real-Time Pyrophosphate , 1998, Science.

[5]  F. Pontén,et al.  Molecular pathology in basal cell cancer with p53 as a genetic marker , 1997, Oncogene.

[6]  F. Pontén,et al.  Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. , 1997, The American journal of pathology.

[7]  F. Pontén,et al.  Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. , 1996, Oncogene.

[8]  F. Pontén,et al.  Sequence-based analysis of the human p53 gene based on microdissection of tumor biopsy samples. , 1994, BioTechniques.

[9]  C. Harris,et al.  p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.

[10]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[11]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[12]  M. Uhlén,et al.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.

[13]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Ronaghi,et al.  Production, purification, and luminometric analysis of recombinant Saccharomyces cerevisiae MET3 adenosine triphosphate sulfurylase expressed in Escherichia coli. , 1999, Protein expression and purification.